Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0005. Calithera Biosciences shares last traded at $0.0005, with a volume of 345 shares trading hands.
Calithera Biosciences Trading Up 9,900.0%
About Calithera Biosciences
Calithera’s lead investigational product was telaglenastat (also known as CB-839), an oral inhibitor of glutaminase, an enzyme involved in glutamine metabolism.
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
